tiprankstipranks
Trending News
More News >
Medicure Inc (TSE:MPH)
:MPH
Advertisement

Medicure (MPH) Price & Analysis

Compare
7 Followers

MPH Stock Chart & Stats


Medicure News

MPH FAQ

What was Medicure Inc’s price range in the past 12 months?
Medicure Inc lowest stock price was C$0.63 and its highest was C$1.33 in the past 12 months.
    What is Medicure Inc’s market cap?
    Medicure Inc’s market cap is C$12.00M.
      When is Medicure Inc’s upcoming earnings report date?
      Medicure Inc’s upcoming earnings report date is Nov 19, 2025 which is in 81 days.
        How were Medicure Inc’s earnings last quarter?
        Medicure Inc released its earnings results on Aug 20, 2025. The company reported -C$0.075 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.075.
          Is Medicure Inc overvalued?
          According to Wall Street analysts Medicure Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Medicure Inc pay dividends?
            Medicure Inc does not currently pay dividends.
            What is Medicure Inc’s EPS estimate?
            Medicure Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Medicure Inc have?
            Medicure Inc has 10,436,313 shares outstanding.
              What happened to Medicure Inc’s price movement after its last earnings report?
              Medicure Inc reported an EPS of -C$0.075 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Medicure Inc?
                Currently, no hedge funds are holding shares in TSE:MPH

                Company Description

                Medicure Inc

                Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

                Medicure (MPH) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Theratechnologies
                Crescita Therpeutc
                Mountain Valley MD
                Medexus Pharmaceuticals Inc
                Revive Therapeutics

                Ownership Overview

                24.73%75.27%
                24.73% Insiders
                Mutual Funds
                ― Other Institutional Investors
                75.27% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis